Synthesis and Characterization of Impurities of Eletriptan and its HPLC Method Development and Validation

  • Moovi Nema College of pharmacy, Sri Satya Sai University of Technology and Medical Sciences, Sehore, Madhya pradesh
  • Avinash Gawali Department of pharmacy, N.D.M.V.P’ s Samaj College of Pharmacy, Nashik, Maharashtra
  • S B Wagh Department of pharmacy, N.D.M.V.P’ s Samaj College of Pharmacy, Nashik, Maharashtra
  • H K Sharma College of pharmacy, Sri Satya Sai University of Technology and Medical Sciences, Sehore, Madhya pradesh

Abstract

A simple, precise, rapid and accurate HPLC method was developed and validated for the identification and evaluation of N-acetyl 5- (phenyl sulfonylethen 2-yl) indole and 5- (phenyl sulfonyl ethen2-yl)-1H-indole impurities of eletriptan formed during Eletriptan Synthesis. The synthesis of the impurity standard with the proposed structure is the important step in impurity profiling. Characterization of these impurities are done by using instruments like GC-MS ,NMR and FTIR. Separation was carried on a Waters 1525 HPLC system with Breeze software, Waters 2489 UV/Visible detector and Waters Xterra Phenyl C18 analytical column (250mm x4.6mm: 5 µ) was operated in a gradient mode at a flow rate of 1 ml/min with detection wavelengh of 225nm by an injection volume of 10ul. The method is Validated as per ICH guidelines by determining its specificity, accuracy, precision, linearity, ruggedness, robustness and system suitability. 

Keywords: GC-MS, NMR, FTIR, Validation, Eletriptan

References

1.Tripathi KD . Essentials of medical pharmacology fifth edition. Jaypee brothers medical publishers(p) Ltd, New Delhi, 139 -143.
2.Roy J. Pharmaceutical Impurities A Mini-Review. AAPS PharmSciTech 2002; 3 (2) article 6:1-8
3.Rao KS et al. synthesis and characterization of related impurities of Eletriptan Hydrobromide. international Research journal of pharmacy,2012;3(10):119-122
4.International Conferences on Harmonization, Draft Revised Guidance on Impurities in New Drug Substances, Q3A(R), Federal Register, 2000, 65 (140),.45085.
5.International Conferences on Harmonization, Draft Revised Guidance on impurities in New Drug products, Q3B(R), Federal Register, 2000, 65 (139),. 44791.
6.International Conference on Harmonization (1999) Specifications, Q6A: Test Procedures and Acceptance Criterial for New Drug Substances and New DrugProducts. Chemical substances 65 (146):67488.
7.Kumar KS et al. Synthesis and characterization of potential impurities in key intermediates of Carvedilol: a b-adrenergic receptor. J. Chem. Pharm. Res. 2011; 3(6):33-45
8.Mendham J, Denney RC, Barnes JD, Thomas M. Vogel’s Textbook of Quantitative Analysis. Pearson Education, Singapore, 2003; 361-288.
9.USP-NF, Validation of Compendial Procedures, Genral Chapters,Volume-1; 2010:734-736.
Statistics
36 Views | 37 Downloads
How to Cite
Nema, M., A. Gawali, S. B. Wagh, and H. K. Sharma. “Synthesis and Characterization of Impurities of Eletriptan and Its HPLC Method Development and Validation”. Current Research in Pharmaceutical Sciences, Vol. 6, no. 3, Sept. 2016, pp. 74-81, http://crpsonline.com/index.php/crps/article/view/164.
Section
Research Articles